Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial [electronic resource] : a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis / Ball S, Vickery J, Hobart J, ... [et. al.].